Susan C Miller1, Shubing Cai2, Lori A Daiello1,3,4, Theresa I Shireman1, Ira B Wilson1. 1. Department of Health Services, Policy & Practice, Brown University School of Public Health, Providence, Rhode Island. 2. Department of Public Health Sciences, School of Medicine and Dentistry, University of Rochester Medical Center, Rochester, New York. 3. Department of Neurology, Warren Alpert Medical School of Brown University, Providence, Rhode Island. 4. Alzheimer's Disease and Memory Disorders Center, Rhode Island Hospital, Providence, Rhode Island.
Abstract
OBJECTIVES: Given an aging human immunodeficiency virus (HIV) population, we aimed to determine the prevalence of HIV for long-stay residents in US nursing homes (NHs) between 2001 and 2010 and to compare characteristics and diagnoses of HIV-positive (HIV+) and negative (HIV-) residents. Also, for residents with dementia diagnoses, we compared antipsychotic (APS) medication receipt by HIV status. DESIGN: A cross-sectional comparative study. SETTING: NHs in the 14 states accounting for 75% of persons living with HIV. PARTICIPANTS: A total of 9 245 009 long-stay NH residents. MEASUREMENTS: Using Medicaid fee-for-service claims data in the years 2001 to 2010, together with Medicare resident assessment and Chronic Condition Warehouse data, we identified long-stay (more than 89 days) NH residents by HIV status and dementia presence. We examined dementia presence by age groups and APS medication receipt by younger (aged younger than 65 years) vs older (aged 65 years or older) residents, using logistic regression. RESULTS: Between 2001 and 2010, the prevalence of long-stay residents with HIV in NHs increased from 0.7% to 1.2%, a 71% increase. Long-stay residents with HIV were younger and less often female or white. For younger NH residents, rates of dementia were 20% and 16% for HIV+ and HIV- residents, respectively; they were 53% and 57%, respectively, for older residents. In adjusted analyses, younger HIV+ residents with dementia had greater odds of APS medication receipt than did HIV- residents (AOR = 1.3; 95% confidence interval [CI] = 1.2-1.4), but older HIV residents had lower odds (AOR = 0.9; 95% CI = 0.8-0.9). CONCLUSION: The prevalence of long-stay HIV+ NH residents has increased over time, and given the rapid aging of the HIV population, this increase is likely to have continued. This study raises concern about potential differential quality of care for (younger) residents with HIV in NHs, but not for those aged 65 years and older. These findings contribute to the evidence base needed to ensure high-quality care for younger and older HIV+ residents in NHs.
OBJECTIVES: Given an aging human immunodeficiency virus (HIV) population, we aimed to determine the prevalence of HIV for long-stay residents in US nursing homes (NHs) between 2001 and 2010 and to compare characteristics and diagnoses of HIV-positive (HIV+) and negative (HIV-) residents. Also, for residents with dementia diagnoses, we compared antipsychotic (APS) medication receipt by HIV status. DESIGN: A cross-sectional comparative study. SETTING: NHs in the 14 states accounting for 75% of persons living with HIV. PARTICIPANTS: A total of 9 245 009 long-stay NH residents. MEASUREMENTS: Using Medicaid fee-for-service claims data in the years 2001 to 2010, together with Medicare resident assessment and Chronic Condition Warehouse data, we identified long-stay (more than 89 days) NH residents by HIV status and dementia presence. We examined dementia presence by age groups and APS medication receipt by younger (aged younger than 65 years) vs older (aged 65 years or older) residents, using logistic regression. RESULTS: Between 2001 and 2010, the prevalence of long-stay residents with HIV in NHs increased from 0.7% to 1.2%, a 71% increase. Long-stay residents with HIV were younger and less often female or white. For younger NH residents, rates of dementia were 20% and 16% for HIV+ and HIV- residents, respectively; they were 53% and 57%, respectively, for older residents. In adjusted analyses, younger HIV+ residents with dementia had greater odds of APS medication receipt than did HIV- residents (AOR = 1.3; 95% confidence interval [CI] = 1.2-1.4), but older HIV residents had lower odds (AOR = 0.9; 95% CI = 0.8-0.9). CONCLUSION: The prevalence of long-stay HIV+ NH residents has increased over time, and given the rapid aging of the HIV population, this increase is likely to have continued. This study raises concern about potential differential quality of care for (younger) residents with HIV in NHs, but not for those aged 65 years and older. These findings contribute to the evidence base needed to ensure high-quality care for younger and older HIV+ residents in NHs.
Authors: M Margallo-Lana; A Swann; J O'Brien; A Fairbairn; K Reichelt; D Potkins; P Mynt; C Ballard Journal: Int J Geriatr Psychiatry Date: 2001-01 Impact factor: 3.485
Authors: P A Selwyn; J L Goulet; S Molde; J Constantino; K P Fennie; P Wetherill; D M Gaughan; H Brett-Smith; C Kennedy Journal: J Urban Health Date: 2000-06 Impact factor: 3.671
Authors: Bruce E Landon; Ira B Wilson; Neil S Wenger; Susan E Cohn; Carl J Fichtenbaum; Samuel A Bozzette; Martin F Shapiro; Paul D Cleary Journal: J Gen Intern Med Date: 2002-01 Impact factor: 5.128
Authors: Vincent Mor; Joseph Angelelli; Richard Jones; Jason Roy; Terry Moore; John Morris Journal: BMC Health Serv Res Date: 2003-11-04 Impact factor: 2.655
Authors: David J Meyers; Ira B Wilson; Yoojin Lee; Shubing Cai; Susan C Miller; Momotazur Rahman Journal: J Am Geriatr Soc Date: 2019-08-29 Impact factor: 5.562
Authors: Tingting Zhang; Ira B Wilson; Andrew R Zullo; David J Meyers; Yoojin Lee; Lori A Daiello; Dae Hyun Kim; Douglas P Kiel; Theresa I Shireman; Sarah D Berry Journal: J Am Med Dir Assoc Date: 2021-09-25 Impact factor: 7.802